[go: up one dir, main page]

AU2002212456A1 - Use of an ep2 or ep4 receptor antagonist and/or a cox-1 inhibitor for treating cervical cancer - Google Patents

Use of an ep2 or ep4 receptor antagonist and/or a cox-1 inhibitor for treating cervical cancer

Info

Publication number
AU2002212456A1
AU2002212456A1 AU2002212456A AU2002212456A AU2002212456A1 AU 2002212456 A1 AU2002212456 A1 AU 2002212456A1 AU 2002212456 A AU2002212456 A AU 2002212456A AU 2002212456 A AU2002212456 A AU 2002212456A AU 2002212456 A1 AU2002212456 A1 AU 2002212456A1
Authority
AU
Australia
Prior art keywords
cox
inhibitor
receptor antagonist
cervical cancer
treating cervical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212456A
Inventor
Henry Nicolas Jabbour
Arieh Katz
Kurt Jason Sales
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU2002212456A1 publication Critical patent/AU2002212456A1/en
Abandoned legal-status Critical Current

Links

AU2002212456A 2001-10-31 Use of an ep2 or ep4 receptor antagonist and/or a cox-1 inhibitor for treating cervical cancer Abandoned AU2002212456A1 (en)

Publications (1)

Publication Number Publication Date
AU2002212456A1 true AU2002212456A1 (en) 2003-05-12

Family

ID=

Similar Documents

Publication Publication Date Title
IL159588A0 (en) Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor
IL173081A0 (en) Use of combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer
AU2001282886A1 (en) Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
AU2003275128A1 (en) Isolation and use of ryanodine receptors
IL172875A0 (en) Dosage forms providing controlled release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors
AU2003303128A1 (en) Inhibitors and methods of use thereof
IL166625A0 (en) Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancer
AP2003002719A0 (en) Use of cox-2 inhibitors for preventing immunodeficiency
EP1121939A3 (en) Treatment of osteoporosis with EP2/EP4 receptor selective agonists
AU2002255243A1 (en) Device for aiding urination and method of use thereof
AU2002227123A1 (en) Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2003210983A1 (en) Kinase inhibitors and methods of use thereof
AU2002367730A1 (en) Use of leukotriene receptor antagonist for treatment of scarring
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU3270301A (en) Combined pde3 and pde4 inhibitor therapy for the treatment of obesity
HRP20040909A2 (en) Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
AU2002212456A1 (en) Use of an ep2 or ep4 receptor antagonist and/or a cox-1 inhibitor for treating cervical cancer
AU2002246924A1 (en) Treatment of erectile dysfunction with rho-kinase inhibitors
AU2003237076A1 (en) Therapeutical use of anti-cd70 antibody for treating or preventing aids
AU2002222191A1 (en) Use of ep4 receptor agonists for treating neuropathic pain
EP1225885A4 (en) A therapeutic mixture of hmg-coa reductase inhibitors
IL163605A0 (en) Use of an inhibitor or antagonist against tissue factor
AU2002305868A1 (en) Inhibitors of reggamma
AU2177701A (en) Use of hmg-coa reductase inhibitors for treating seborrhea